147 related articles for article (PubMed ID: 11189690)
21. Factors affecting older african american women's decisions to join the PLCO Cancer Screening Trial.
Trauth JM; Jernigan JC; Siminoff LA; Musa D; Neal-Ferguson D; Weissfeld J
J Clin Oncol; 2005 Dec; 23(34):8730-8. PubMed ID: 16314633
[TBL] [Abstract][Full Text] [Related]
22. ERSPC, PLCO studies and critique of cochrane review 2013.
Schröder FH
Recent Results Cancer Res; 2014; 202():59-63. PubMed ID: 24531778
[TBL] [Abstract][Full Text] [Related]
23. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Doria-Rose VP; Laiyemo AO; Church T; Yokochi LA; Yurgalevitch S; Rathmell J; Andriole GL; Buys S; Crawford ED; Fouad M; Isaacs C; Lamerato L; Reding D; Prorok PC; Berg CD;
J Natl Cancer Inst; 2012 Feb; 104(4):280-9. PubMed ID: 22298838
[TBL] [Abstract][Full Text] [Related]
24. Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.
Lamerato LE; Marcus PM; Jacobsen G; Johnson CC
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):827-33. PubMed ID: 18398023
[TBL] [Abstract][Full Text] [Related]
25. Data Processing and Analytic Support in the PLCO Cancer Screening Trial.
Mabie J; Riley T; Marcus PM; Black A; Rozjabek H; Yu K; Young M; Austin J; Rathmell J; Williams C; Prorok PC
Rev Recent Clin Trials; 2015; 10(3):233-7. PubMed ID: 26238116
[TBL] [Abstract][Full Text] [Related]
26. Cumulative incidence of false-positive results in repeated, multimodal cancer screening.
Croswell JM; Kramer BS; Kreimer AR; Prorok PC; Xu JL; Baker SG; Fagerstrom R; Riley TL; Clapp JD; Berg CD; Gohagan JK; Andriole GL; Chia D; Church TR; Crawford ED; Fouad MN; Gelmann EP; Lamerato L; Reding DJ; Schoen RE
Ann Fam Med; 2009; 7(3):212-22. PubMed ID: 19433838
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
[TBL] [Abstract][Full Text] [Related]
28. Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.
Grubb RL; Pinsky P; Prorok PC; Andriole GL
Eur Urol; 2015 Oct; 68(4):545-6. PubMed ID: 25959167
[TBL] [Abstract][Full Text] [Related]
29. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.
Kramer BS; Gohagan J; Prorok PC; Smart C
Cancer; 1993 Jan; 71(2 Suppl):589-93. PubMed ID: 8420681
[TBL] [Abstract][Full Text] [Related]
30. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Pinsky PF; Ford M; Gamito E; Higgins D; Jenkins V; Lamerato L; Tenorio S; Marcus PM; Gohagan JK
J Natl Med Assoc; 2008 Mar; 100(3):291-8. PubMed ID: 18390022
[TBL] [Abstract][Full Text] [Related]
31. Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial.
Bazzi L; Lamerato LE; Varner J; Shambaugh VL; Cordes JE; Ragard LR; Marcus PM
Rev Recent Clin Trials; 2015; 10(3):200-5. PubMed ID: 26238207
[TBL] [Abstract][Full Text] [Related]
32. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.
Taylor KL; Shelby R; Gelmann E; McGuire C
J Natl Cancer Inst; 2004 Jul; 96(14):1083-94. PubMed ID: 15265970
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.
Gohagan JK; Prorok PC; Kramer BS; Cornett JE
J Urol; 1994 Nov; 152(5 Pt 2):1905-9. PubMed ID: 7523735
[TBL] [Abstract][Full Text] [Related]
34. Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.
Pinsky PF; Andriole GL; Kramer BS; Hayes RB; Prorok PC; Gohagan JK;
J Urol; 2005 Mar; 173(3):746-50; discussion 750-1. PubMed ID: 15711261
[TBL] [Abstract][Full Text] [Related]
35. Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.
Pierre-Victor D; Pinsky PF
JAMA Intern Med; 2019 Feb; 179(2):196-203. PubMed ID: 30592477
[TBL] [Abstract][Full Text] [Related]
36. The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.
Carrick DM; Black A; Gohagan JK; Khan A; Pettit K; Williams C; Yu K; Yurgalevitch S; Huang WY; Zhu C
Rev Recent Clin Trials; 2015; 10(3):212-22. PubMed ID: 26238117
[TBL] [Abstract][Full Text] [Related]
37. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
[TBL] [Abstract][Full Text] [Related]
38. The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.
Zhu CS; Pinsky PF; Kramer BS; Prorok PC; Purdue MP; Berg CD; Gohagan JK
J Natl Cancer Inst; 2013 Nov; 105(22):1684-93. PubMed ID: 24115361
[TBL] [Abstract][Full Text] [Related]
39. PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.
Black A; Huang WY; Wright P; Riley T; Mabie J; Mathew S; Ragard L; Hermansen S; Yu K; Pinsky P; Prorok PC; Freedman ND; Hoover RN
Rev Recent Clin Trials; 2015; 10(3):238-45. PubMed ID: 26435289
[TBL] [Abstract][Full Text] [Related]
40. Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Miller AB; Feld R; Fontana R; Gohagan JK; Jatoi I; Lawrence W; Miller A; ProroK PC; Rajput A; Sherman M; Welch G; Wright P; Yurgalevitch S; Albertsen P
Rev Recent Clin Trials; 2015; 10(3):206-11. PubMed ID: 26238119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
